CytRx Corporation (OTCMKTS:CYTR) Stock Falls:Company Relaunches as LadRx Corporation

September 26, 2022

Biopharmaceutical innovator focusing on research and development of life-saving cancer therapeutics, CytRx Corporation (OTCMKTS:CYTR), on September 23, 2022, announced relaunching of the LadRx Corporation. Trading Data On Friday, CYTR stock slid 21.57% to $0.1000 with more than 90.12K shares, compared to its average volume of 68.32K shares. The stock moved within a range of $0.1000 – 0.1275 after opening trading at $0.1003. CytRx Corporation Relaunches as LadRx Corporation Chief Executive…

Read More >>

CytRx Corporation (OTCMKTS:CYTR) Stock On Radar After Patent News

September 8, 2022

Biopharmaceutical innovator CytRx Corporation (OTCMKTS:CYTR) was in the news yesterday after it made a major new announcement with regards to the receipt of a key patent. For an innovative company that can often be seen as a significant development. Trading Data On Wednesday, CYTR stock fell 2.77% to $0.0824 with 23.32K shares, compared to volume of 66.64K shares. The stock moved within a range of $0.0787 – 0.0897 after opening…

Read More >>